Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
James P. Scriven, CEO of IDB Invest, focuses on Latin American finance and development in collaboration with the International Finance Corporation.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
James P. Scriven, CEO of IDB Invest
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
David Wilkinson, President and General Manager of Retail at NCR, speaks from their modern headquarters in Atlanta, Georgia.|Michael D. Hayford Retiring as NCR Chief Executive Officer
00:10:00
CEO's Call to Confront Injustice and Lead with Purpose | Michael Hankin, CEO , Brown Advisory LLC.
00:10:00
Developing a portfolio of innovative products|James Barder,Chief Executive,Futura Medical
00:10:00
Navigating the Changing IPO Landscape: Insights from a 50-Year Veteran
00:00:00
Research is focused on the economics of mental health / Richard G. Frank, PhD Margaret T. Morris Professor of Health Economics, Department of Health Care Policy, Harvard Medical School
00:10:00
Opportunities for entering the global market|Alexey Girin,Founder and General Partner,Starta VC
00:10:00
CTT Correios de Portugal SA | João Bento, CEO, CTT Correios de Portugal SACTT:LIS
00:10:00
"Exploring Eduardo Gallardo: An Insightful Profile" | Eduardo Gallardo - Partner, Corporate Department of Paul Hastings LLP
00:10:00
Common Retirement Planning Mistakes and How to Avoid Them | Ken Fisher, founder , Fisher Investments.
00:10:00
Martin Vohánka, CEO of Eurowag, Shares the Company’s Vision and Ambition | Martin Vohánka, CEO, W.A.G. Payment Solutions PLC.
00:10:00
Supriya Lifescience IPO Opens on December 16; Aiming to Raise ₹500 Crore at ₹265-274 Price Band | Satish Wagh, Chairman, Supriya Lifescience Limited.
00:10:00
Update on Asante Gold: Refurbishment Progress and Future Production Expectations